Cardiovascular-related, immunovirologic and biomarkers data in control subjects and HIV-infected patients at baseline and 48 weeks after initiating ART.

BMI = Body mass index. CMV = cytomegalovirus, NS = Not significant. NA = Not applicable. a) p for control subjects vs. naive HIV patients. b) p for control subjects vs. HIV patients with 48 weeks of ART. c) p for comparison of HIV patients at baseline vs. 48 weeks. d) Proportion of HIV patients with undetectable viral load at 48 weeks. e) Values calculated using the only 3 patients with detectable viral loads at 48 weeks (with descriptive aims, no comparison).